Results 181 to 190 of about 331,389 (305)
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen +7 more
wiley +1 more source
Comparative analysis of zebrafish, organoid, and organ-on-chip models in breast cancer research. [PDF]
Alzaharani R, Alghadmi MA, Amiri M.
europepmc +1 more source
Agglomeration and comparative advantage in vertically-related firms
José Pedro Pontes
openalex +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Beyond Precision: Why the Future of Robotic Joint Arthroplasty Demands Continued Research. [PDF]
Bullock M, Danoff JR.
europepmc +1 more source
CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao +7 more
wiley +1 more source
Reassessing oncologic adequacy and methodological rigor in minimally invasive surgery for remnant gastric cancer. [PDF]
Un Nisa N +4 more
europepmc +1 more source
Comments on SEE: Comparative Advantages and and Experimental Consequences
Larry L. Smalley
openalex +1 more source

